- MetAlert, formerly GTX Corp, trades under the temporary ticker symbol: OTC: GTXOD.
- A permanent new symbol will be issued and announced after 20 days of trading under GTXOD, expected to be around Oct 18th
- Over the next few weeks, the Company will be announcing more information on new strategic partnerships and product launches; here is a closer look at what we can expect.
MetAlert (OTC: GTXOD), known throughout the industry as an innovative leader in the field of wearable technology, has a fresh new look. The Company is evolving and rebranding to reflect its broader vision of solutions that improve health, safety, wellness, longevity, and quality of life.
MetAlert is taking everything it was under the GTX Corp brand but now will be adding new partnerships and products, which will encompass a much more comprehensive look into the future of medical technology.
Metalert has always been a company to watch. They were one of the first to bring GPS wearable technology to the market and continue to be a leader in the field. Now, they are expanding their product offerings to include telemedicine services, other wearables that integrate with their GPS SmartSole platform, and new fall detection and remote patient monitoring (RPM) product called RoomMate.
According to the CDC:
- Annual medical costs for falls total more than $50 billion and are expected to rise.
- More than 800,000 patients are hospitalized yearly because of a fall injury.
- A large percentage of falls often result in a broken hip or head injury.
- The average hospital cost for a fall injury is more than $30,000 and is expected to grow.
Fall Detection and RPM- saves money and saves lives!
RoomMate is the latest and most advanced remote monitoring and fall detection system on the market today. It is a simple-to-use solution for remotely looking after patients without intruding on their personal space, allowing for a total ‘anonymized’ supervision and monitoring service using Infrared 3D technology. With these new products, Metalert is positioning itself as a one-stop shop for all your wearable technology needs.
The Need for Telemedicine Services.
As the population ages, there is an increasing need for telemedicine services. According to a report by Grand View Research, the global telemedicine market is expected to reach $176.8 billion by 2025. This growth is driven by several factors, including an aging population, the increasing prevalence of chronic diseases, and rising healthcare costs. MetAlert’s telemedicine services will allow patients to consult with doctors and other healthcare professionals from the comfort of their own homes. This will save them and their caregivers time and money and provide an early diagnosis that can lead to a higher quality or even longer life, ensuring peace of mind for all.
Medical Devices That Integrate with The GPS SmartSole Platform.
The GPS SmartSole platform is MetAlert’s flagship product. It is an orthotic insole embedded with a GPS, cellular, wi-fi, and Bluetooth module. It is designed to monitor people with dementia, Alzheimer’s, or autism who tend to get lost and disoriented. The platform allows caregivers to track the whereabouts of their loved ones in real time and receive alerts if they wander off. With the launch of new products that integrate with the GPS SmartSole platform, Metalert is expanding its offerings to include products that will monitor overall health, such as temperature, heart rate, oxygen intake, and more. The devices will connect via Bluetooth to the SmartSole, and the SmartSole via cellular will send the information to the cloud; hence the GPS SmartSole will act as an invisible mobile hot spot or a Hub. Connecting these devices that are constantly monitoring vitals will increase the safety of those who use them and give caregivers peace of mind knowing that their loved ones are being monitored around the clock.
Conclusion:
MetAlert is a company that is constantly innovating and expanding its product offerings. With the recent announcement of the rebranding and future launch of some of these products, they are positioning themselves as a one-stop shop for all your remote patient monitoring technology needs. Whether you are looking for a way to keep an eye on your elderly parent or need a device to help you manage your diabetes, MetAlert has or is working on a solution. So be sure to check out their website today www.metalert.com and see how they can help you live your life more safely and securely!
While the new ticker symbol will not be formally announced until mid-October, investors who want to invest in MetAlert now can do so under the temporary ticker symbol of GTXOD. Current shares will automatically be transferred to the new ticker symbol when the new symbol becomes effective. In an aging world where dementia, autism, and other neurological disorders require patients to be monitored and kept safe, MetAlert is making a challenging situation a little bit easier for everyone involved!
(OTC: GTXOD)
Disclaimer Statement: This article is strictly the author’s opinion. All stocks involve risks and the possibility of losing all your investment. Please consider all risks before investing and consult an investment advisor if you lack experience. Article provided and paid for by Strategic Innovations First, who the companies mentioned pay for social media and research information. The companies have not approved or endorsed this article.
